References

  1. Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ. 1998;76(Suppl 2):22-25. PubMed | Google Scholar

  2. Orenstein WA, Papania MJ. Defining and Assessing Measles Elimination Goals. J Infect Dis. 2004;189(Supplement 1):S23-S26. PubMed | Google Scholar

  3. Moss WJ, Strebel P. Biological Feasibility of Measles Eradication. J Infect Dis. 2011;204(Suppl 1):S47-S5. PubMed | Google Scholar

  4. Orenstein WA, Papania MJ, Wharton ME. Measles Elimination in the United States. J Infect Dis. 2004;189(Supplement 1):S1-S3. PubMed | Google Scholar

  5. Masresha B, Fall A, Luce R, Eshetu M, Kaiser R, Dosseh A et al. Measles elimination in the WHO African Region: Progress and challenges. Accessed 24 May 2018.

  6. World Health Organization. Global Measles and Rubella Strategic Plan. 2012. Accessed 24 May 2018.

  7. Gay NJ. The Theory of Measles Elimination: Implications for the Design of Elimination Strategies. J Infect Dis. 2004;189(s1):S27-S35. PubMed | Google Scholar

  8. Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N. Supplementary Immunization Activities to Achieve Measles Elimination: Experience of the European Region. J Infect Dis. 2011;204(suppl 1):S343-S352. PubMed | Google Scholar

  9. World Health Organization. Planning and Implementing High-Quality Supplementary Immunization Activities for Injectable Vaccines Using an Example of Measles and Rubella Vaccines. Accessed 24 May 2018.

  10. Ministry of Health Kenya. Measles Vaccine Second Dose Introduction in Routine Immunization a Guide for Health Workers. Accessed 24 May 2018.

  11. WHO Regional Office for Africa. African Regional Guidelines for Measles and Rubella Surveillance. Accessed 24 May 2018.

  12. Ministry of Health Kenya. Technical Guidelines for Integrated Disease Surveillance and Response in Kenya. 2nd ed.

  13. Weldegebriel GG, Gasasira A, Harvey P, Masresha B, Goodson JL, Pate MA et al. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008. J Infect Dis. 2011; 204(SUPPL 1):2005-2008. PubMed | Google Scholar

  14. Scobie HM, Ilunga BK, Mulumba A, Shidi C, Coulibaly T, Obama R et al. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo. Pan Afr Med J. 2015;21:30. PubMed | Google Scholar

  15. Lowther SA, Curriero FC, Kalish BT, Shields TM, Monze M, Moss WJ. Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey. Lancet. 2009;373(9668):1025-1032. PubMed | Google Scholar

  16. Strebel PM, Henao-Restrepo A, Hoekstra E, Olivé J, Papania MJ, Cochi SL et al. Global Measles Elimination Efforts: The Significance of Measles Elimination in the United States. J Infect Dis. 2004; 189(s1):S251-S257. PubMed | Google Scholar

  17. United Republic of Tanzania. WHO and UNICEF estimates of immunization coverage: 2017 revision. Accessed 18 June 2018.

  18. Haji A, Lowther S, Ngan'ga Z, Gura Z, Tabu C, Sandhu H et al. Reducing routine vaccination dropout rates: evaluating two interventions in three Kenyan districts, 2014. BMC Public Health. 2016;16:152. PubMed | Google Scholar

  19. Manakongtreecheep K, Davis R. A review of measles control in Kenya, with focus on recent innovations. Pan Afr Med J. 2017;27. PubMed | Google Scholar